How bacteria communicate and develop traits that affect infections.
Intercellular Communication and Pheromone Maturation in Gram-Positive Bacteria.
This study is looking at how certain bacteria, like Staphylococcus aureus, use tiny signals called pheromones to talk to each other and control how harmful they can be, which could help us understand infections better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10836385 on NIH RePORTER |
What this research studies
This research investigates how gram-positive bacteria, such as Staphylococcus aureus, use small signaling molecules called pheromones to communicate and regulate their virulence. By focusing on a specific type of pheromone known as cyclic auto-inducing peptides (AIPs), the project aims to understand the processes involved in their production and signaling. The researchers will explore the proteins necessary for AIP processing and identify transport mechanisms, which could reveal new insights into bacterial behavior and infection mechanisms.
Who could benefit from this research
Good fit: Patients with infections caused by gram-positive bacteria, such as those with Staphylococcus aureus infections, would be ideal candidates to benefit from this research.
Not a fit: Patients with infections caused by gram-negative bacteria or those unrelated to bacterial infections may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing and treating bacterial infections by targeting their communication systems.
How similar studies have performed: Previous research has shown that targeting bacterial communication systems can be effective in reducing virulence, indicating that this approach has potential for success.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Alonzo, Francis — University of Illinois at Chicago
- Study coordinator: Alonzo, Francis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.